Home / Insights / Vaxxas Initiates Program With Merck to Optimize Delivery of Next Generation Vaccines Utilizing Novel Mechanism for Immune System Activation

Vaxxas Initiates Program With Merck to Optimize Delivery of Next Generation Vaccines Utilizing Novel Mechanism for Immune System Activation

08 October 2012

Posted in — OneVentures

Learn More

Abbie Lewis

Author

Abbie Lewis

Abbie plays a key role in delivering OneVentures’ marketing, PR, community and branding initiatives, strengthening the firm’s identity and amplifying the visibility of our portfolio companies. Before joining OneVentures, Abbie worked at 89up in London, Europe’s first impact PR agency, where she contributed to global campaigns for NGOs.

You may also like

10 June 2023

Healthcare

Biotech ImmVirX bucks VC desert to bank raise at $75m valuation

Read the full article: Australian Financial Review
afr.com/technology/biotech-immvirx-bucks-vc-desert-to-bank-raise-at-75m-valuation-20230604-p5ddrw

18 June 2023

Healthcare

Vaxxas opens world-class manufacturing facility to produce needle-free vaccine patch

Read the full article: Vaxxas
businesswire.com/news/home/20230618635444/en/Vaxxas-Opens-World-Class-Manufacturing-Facility-To-Produce-Proprietary-Needle-Free-Vaccine-Patch-For-Late-Stage-Clinical-Trials-and-First-Commercial-Products

06 December 2022

Healthcare

Needle-free vaccine innovator banks $34m

Read the full article: The Australian Financial Review
afr.com/technology/needle-free-vaccine-innovator-banks-34m-20221202-p5c39x

10 November 2021

Healthcare

Vaxxas recognised in the Top 10 healthcare startups in Australia, 2021

Read the full article: Startup Lanes
www-startuplanes-com.cdn.ampproject.org/c/s/www.startuplanes.com/top-10-healthcare-startups-in-australia/amp/

View All